New pharmaceutical target reverses osteoporosis in mice
Biomedical engineers have discovered that an adenosine receptor called A2B can be pharmaceutically activated to reverse bone degradation caused by osteoporosis in mouse models of the disease.
View ArticleTerrosa osteoporosis biosimilar treatment launched in Europe
A new biosimilar drug to treat osteoporosis is now available across Europe after the patent for its reference product expired.The post Terrosa<sup>
View ArticleHormone replacement therapy osteoporosis and breast cancer risk expert analysis
The risk of breast cancer when using hormone replacement therapy HRT is higher than previously thought and continues when HRT is stopped says a report in The Lancet. But Royal Osteoporosis Society...
View ArticleRoyal Osteoporosis Society receives £ million donation to help find a cure...
The Royal Osteoporosis Society has received a £ million donation from the Julia and Hans Rausing Trust to help find a cure for the devastating bone disease. The charity was formerly the National...
View ArticleIOF Compendium highlights urgent need to maintain mobility in older populations
Presenting many new facts and figures a 2nd edition of the International Osteoporosis Foundation Compendium of Osteoporosis has been launched to mark World Osteoporosis Day.
View ArticleNew IOFESCEO position paper offers practical guidance for osteoporosis...
International Osteoporosis Foundation The position paper summarizes the 2018 'European guidance for the diagnosis and management of osteoporosis in postmenopausal women' in an international setting...
View ArticleOsteoporosis declared as 'silent epidemic' shows new survey
A new European survey released today by UCB reveals that bone specialists believe osteoporosis and fragility fractures are neglected and under prioritized by their healthcare systems and action needs...
View ArticleDrug Trials Snapshot EVENITY
EVENITY is a drug to treat osteoporosis thinning and weakening of bone in women after menopause change of life whoare at high risk of breaking a bone fracture or cannot use another osteoporosis...
View ArticleAmgens Osteoporosis Drug Wins European Nod With a Heart Warning
An osteoporosis drug developed by Amgen now has marketing approval in Europe but it carries a warning that the medicine can raise the risk of cardiovascular problems. Romosozumab Evenity treats...
View ArticleAmgenUCBs Evenity receives EC approval to treat osteoporosis
Amgen and UCB have received the European Commission EC approval for Evenity romosozumab to treat severe osteoporosis in postmenopausal women...Read More...The post AmgenUCBs Evenity receives EC...
View ArticleEC approves treatment for severe osteoporosis postmenopausal women
Marketing authorisation has been granted by the EC for Evenity romosozumab to treat osteoporosis in postmenopausal women.The post EC approves treatment for severe osteoporosis postmenopausal women appea
View ArticleEU approves new osteoporosis treatment
Amgen and UCB’s Evenity has been given the green light for postmenopausal women with severe osteoporosis to help prevent further fractures
View ArticleOsteoporosis Screening Often Missed in Patients With ESRD
Women with ESRD on hemodialysis are rarely screened for osteoporosis despite the fact they are at high risk for bone diseases compared with the general population. Medscape Medical News
View ArticleOsteoporosis Drugs Don't Reduce Overall Mortality
Antifracture medications do not reduce overall mortality in older patients with osteoporosis according to an updated systematic review and metaanalysis. Reuters Health Information
View ArticleOsteoporosis Drugs Not Linked to Lower Mortality
Treating osteoporosis with medication like bisphosphonates is not associated with lower mortality risk according to a metaanalysis in JAMA Internal Medicine. Researchers analyzed 38...
View ArticleOsteoporosis Screening in Younger Postmenopausal Women
This JAMA Insights in the Womens Health series summarizes USPSTF recommendations for screening postmenopausal women younger than 65 years for osteoporosis and advises use of the Osteoporosis...
View ArticleEU Approves Amgen's Osteoporosis Drug Evenity
THOUSAND OAKS dpaAFX Amgen AMGN and UCB said Thursday that the European Commission approved Evenity or romosozumab for the treatment of severe osteoporosis in postmenopausal women at high r...
View ArticleOsteoporosis drugs linked to reduced risk of premature death
A large cohort study has revealed a common osteoporosis drug significantly decreases premature mortality risk likely related to a reduction in bone loss.
View ArticleTaking Osteoporosis Drugs Can Reduce Premature Mortality Risk by Up to 39
Osteoporosis is a disease where the bones become more porous and fragile which dramatically increases the risk of bone fractures. It affects about 200 million people worldwide is a progressive disease...
View ArticleStatins Tied to Osteoporosis in DoseDependent Manner
THURSDAY Oct. 10 2019 There is a dosedependent relationship between diagnosis of osteoporosis and statin treatment according to a study published online Sept. 26 in Annals of the Rheumatic...
View ArticleOsteoporosis and ImplantRelated Complications After TSA
Might osteoporosis contribute to an increased risk of implantrelated complications after shoulder arthroplasty Journal of the American Academy of Orthopaedic Surgeons
View ArticleEndocrine Society Advises on Use of Romosozumab for Osteoporosis
Updated guidance for osteoporosis now includes a recommendation for the use of romosozumab but only in severe osteoporosis and not in women with a history of myocardial infarction or stroke. Medscape...
View ArticleGlobalData highlights low diagnosis and treatment rates of osteoporosis
As World Osteoporosis Day approaches 20 October it marks a yearlong campaign dedicated to raising global awareness of this bone disease. A major unmet need in this space is the low rate of diagnosis...
View ArticleUpdate for Osteoporosis Guidelines; Metformin for Childhood Obesity
>MedPage Today The Endocrine Society updated its osteoporosis clinical practice guidelines to cover use of romosozumab Evenity which the FDA approved last year. The Journal of Clinical Endocrinology...
View ArticleNew Osteoporotic Fracture Tx Algorithm; Obesity Meds Underused
>MedPage Today The International Osteoporosis Foundation and European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis ESCEO released a new algorithm for managing...
View Article
